ADIPOQ and obesity disorder: Dysregulation of several obesity-related signaling pathways, primarily the FTO-IRX3 axis33–35 and adiponectin/adiponectin R136,37, suggest that the presence of miR-34c transgenes leads to obesity-associated dysregulation of adipogenesis.